Estradiol/norethindrone/relugolix Interactions
There are 625 drugs known to interact with estradiol/norethindrone/relugolix, along with 25 disease interactions, and 8 alcohol/food interactions. Of the total drug interactions, 157 are major, 450 are moderate, and 18 are minor.
- View all 625 medications that may interact with estradiol/norethindrone/relugolix
- View estradiol/norethindrone/relugolix alcohol/food interactions (8)
- View estradiol/norethindrone/relugolix disease interactions (25)
Most frequently checked interactions
View interaction reports for estradiol / norethindrone / relugolix and the medicines listed below.
- Fentanyl Transdermal System (fentanyl)
- Jornay PM (methylphenidate)
- Liletta (levonorgestrel)
- Lyrica (pregabalin)
- Vitamin D3 (cholecalciferol)
- Xtandi (enzalutamide)
Estradiol/norethindrone/relugolix alcohol/food interactions
There are 8 alcohol/food interactions with estradiol / norethindrone / relugolix.
Estradiol/norethindrone/relugolix disease interactions
There are 25 disease interactions with estradiol / norethindrone / relugolix which include:
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- osteoporosis
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- QT prolongation
- hyperlipidemia
- weight gain
Report options
QR code containing a link to this page
More about estradiol / norethindrone / relugolix
- estradiol/norethindrone/relugolix consumer information
- Compare alternatives
- Reviews (11)
- Side effects
- Dosage information
- During pregnancy
- Drug class: sex hormone combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
